Synspira's Unattributed Round

Synspira raised a round of funding on June 29, 2017.

Synspira developing inhaled therapies for pulmonary diseases, including cystic fibrosis, chronic obstructive pulmonary disease and pneumonia.…

Articles about Synspira's Unattributed Round: